FLOT1 and ovarian serous adenocarcinoma: Compared to the different ovarian tumors from another GEO data set (GSE57477), we found that the levels of FLOT1 mRNA expression were higher in serous ovarian adenocarcinomas (n = 46) and borderline tumors (n = 6) than in benign adenomas (n = 20) (Figure 4D).